-
1
-
-
0015914428
-
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
-
Brazeau P, Vale W, Burnus R, Ling N, Butcher M, Rivier J, Guillemin R 1973 Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
-
(1973)
Science
, vol.179
, pp. 77-79
-
-
Brazeau, P.1
Vale, W.2
Burnus, R.3
Ling, N.4
Butcher, M.5
Rivier, J.6
Guillemin, R.7
-
3
-
-
0346328229
-
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
-
Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C 2003 Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999-1017 (Pubitemid 37540581)
-
(2003)
Nature Reviews Drug Discovery
, vol.2
, Issue.12
, pp. 999-1017
-
-
Weckbecker, G.1
Lewis, I.2
Albert, R.3
Schmid, H.A.4
Hoyer, D.5
Bruns, C.6
-
4
-
-
0028955742
-
Classification and nomenclature of somatostatin receptors
-
Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE, Reisine T 1995 Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16:86-88
-
(1995)
Trends Pharmacol Sci
, vol.16
, pp. 86-88
-
-
Hoyer, D.1
Bell, G.I.2
Berelowitz, M.3
Epelbaum, J.4
Feniuk, W.5
Humphrey, P.P.A.6
O'Carroll, A.M.7
Patel, Y.C.8
Schonbrunn, A.9
Taylor, J.E.10
Reisine, T.11
-
5
-
-
0031023098
-
Sandostatin LAR in acromegalic patients: Long term treatment
-
DOI 10.1210/jc.82.1.23
-
Fløgstad AK, Halse J, Bakke S, Lancranjan I, Marbach P, Bruns C, Jervell J 1997 Sandostatin LAR in acromegalic patients: long-term treatment. J Clin Endocrinol Metab 82:23-28 (Pubitemid 27021264)
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.1
, pp. 23-28
-
-
Flogstad, A.K.1
Halse, J.2
Bakke, S.3
Lancranjan, I.4
Marbach, P.5
Bruns, Ch.6
Jervell, J.7
-
6
-
-
0036148030
-
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly
-
DOI 10.1210/jc.87.1.99
-
Caron P, Beckers A, Cullen DR, Goth MI, Gutt B, Laurberg P, Pico AM, Valimaki M, Zgliczynski W 2002 Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly. J Clin Endocrinol Metab 87:99-104 (Pubitemid 34084677)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.1
, pp. 99-104
-
-
Caron, Ph.1
Beckers, A.2
Cullen, D.R.3
Goth, M.I.4
Gutt, B.5
Laurberg, P.6
Pico, A.M.7
Valimaki, M.8
Zgliczynski, W.9
-
7
-
-
0024117485
-
The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors
-
Lamberts SW 1988 The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9:417-436
-
(1988)
Endocr Rev
, vol.9
, pp. 417-436
-
-
Lamberts, S.W.1
-
8
-
-
0030295163
-
The pharmacological aspects of the treatment of acromegaly
-
DOI 10.1006/phrs.1996.0095
-
Giustina A, Zaltieri G, Negrini F, Wehrenberg WB 1996 The pharmacological aspects of the treatment of acromegaly. Pharmacol Res 34:247-268 (Pubitemid 27095820)
-
(1996)
Pharmacological Research
, vol.34
, Issue.5-6
, pp. 247-268
-
-
Giustina, A.1
Zaltieri, G.2
Negrini, F.3
Wehrenberg, W.B.4
-
9
-
-
2942675021
-
The diagnosis and medical management of advanced neuroendocrine tumors
-
DOI 10.1210/er.2003-0014
-
Kaltsas GA, Besser GM, Grossman AB 2004 The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25:458-511 (Pubitemid 38780668)
-
(2004)
Endocrine Reviews
, vol.25
, Issue.3
, pp. 458-511
-
-
Kaltsas, G.A.1
Besser, G.M.2
Grossman, A.B.3
-
10
-
-
33846813582
-
A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours
-
DOI 10.1517/13543784.16.2.219
-
Strosberg JR, Kvols LK 2007 A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours. Expert Opin Investig Drugs 16:219-224 (Pubitemid 46206635)
-
(2007)
Expert Opinion on Investigational Drugs
, vol.16
, Issue.2
, pp. 219-224
-
-
Strosberg, J.R.1
Kvols, L.K.2
-
11
-
-
0029583845
-
Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation
-
Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, Leung VK, Li MK, Li AK 1995 Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 346:1666-1669 (Pubitemid 26003324)
-
(1995)
Lancet
, vol.346
, Issue.8991-8992
, pp. 1666-1669
-
-
Sung, J.J.Y.1
Chung, S.C.S.2
Yung, M.Y.3
Lai, C.W.4
Lau, J.Y.W.5
Lee, Y.T.6
Leung, V.K.S.7
Li, M.K.K.8
Li, A.K.C.9
-
12
-
-
0031776784
-
Somatostatin analogues in the treatment of thyroid eye disease
-
Krassas GE 1998 Somatostatin analogues in the treatment of thyroid eye disease. Thyroid 8:443-445 (Pubitemid 28252432)
-
(1998)
Thyroid
, vol.8
, Issue.5
, pp. 443-445
-
-
Krassas, G.E.1
-
14
-
-
0141557668
-
Review article: Pharmacological rationale for the use of somatostatin and analogues in portal hypertension
-
DOI 10.1046/j.1365-2036.2003.01657.x
-
Reynaert H, Geerts A 2003 Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Aliment Pharmacol Ther 18:375-386 (Pubitemid 37070235)
-
(2003)
Alimentary Pharmacology and Therapeutics
, vol.18
, Issue.4
, pp. 375-386
-
-
Reynaert, H.1
Geerts, A.2
-
15
-
-
10744228321
-
Octreotide therapy of pediatric hypothalamic obesity: A double-blind, placebo-controlled trial
-
Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X 2003 Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592 (Pubitemid 36724428)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.6
, pp. 2586-2592
-
-
Lustig, R.H.1
Hinds, P.S.2
Ringwald-Smith, K.3
Christensen, R.K.4
Kaste, S.C.5
Schreiber, R.E.6
Rai, S.N.7
Lensing, S.Y.8
Wu, S.9
Xiong, X.10
-
16
-
-
32544456616
-
A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion
-
DOI 10.1038/sj.ijo.0803074, PII 0803074
-
Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J 2006 A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. Int J Obes 30:331-341 (Pubitemid 43237691)
-
(2006)
International Journal of Obesity
, vol.30
, Issue.2
, pp. 331-341
-
-
Lustig, R.H.1
Greenway, F.2
Velasquez-Mieyer, P.3
Heimburger, D.4
Schumacher, D.5
Smith, D.6
Smith, W.7
Soler, N.8
Warsi, G.9
Berg, W.10
Maloney, J.11
Benedetto, J.12
Zhu, W.13
Hohneker, J.14
-
17
-
-
33947537660
-
Use of long-acting somatostatin analogue treatment in diabetic retinopathy
-
Boehm BO 2007 Use of long-acting somatostatin analogue treatment in diabetic retinopathy. Dev Ophthalmol 39:111-121
-
(2007)
Dev Ophthalmol
, vol.39
, pp. 111-121
-
-
Boehm, B.O.1
-
18
-
-
0025988239
-
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin
-
Giustina A, Girelli A, Buffoli MG, Cimino A, Legati F, Valentini U, Giustina G 1991 Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. Diabetes Res Clin Pract 14:47-54.
-
(1991)
Diabetes Res Clin Pract
, vol.14
, pp. 47-54
-
-
Giustina, A.1
Girelli, A.2
Buffoli, M.G.3
Cimino, A.4
Legati, F.5
Valentini, U.6
Giustina, G.7
-
19
-
-
12344298281
-
Pharmacologic therapies for acromegaly: A review of their effects on glucose metabolism and insulin resistance
-
DOI 10.2165/00024677-200504010-00005
-
Pereira AM, Biermasz NR, Roelfsema F, Romijn JA 2005 Pharmacologic therapies for acromegaly: a review of their effects on glucose metabolism and insulin resistance. Treat Endocrinol 4:43-53 (Pubitemid 40129110)
-
(2005)
Treatments in Endocrinology
, vol.4
, Issue.1
, pp. 43-53
-
-
Pereira, A.M.1
Biermasz, N.R.2
Roelfsema, F.3
Romijn, J.A.4
-
20
-
-
23844540615
-
Long-acting somatostatin analog therapy of acromegaly: A meta-analysis
-
DOI 10.1210/jc.2005-0260
-
Freda PU, Katznelson L, van der Lely AJ, Reyes CM, Zhao S, Rabinowitz D 2005 Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J Clin Endocrinol Metab 90:4465-4473 (Pubitemid 41159328)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.8
, pp. 4465-4473
-
-
Freda, P.U.1
Katznelson, L.2
Van Der Lely, A.J.3
Reyes, C.M.4
Zhao, S.5
Rabinowitz, D.6
-
21
-
-
1442326975
-
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
-
DOI 10.1210/er.2002-0022
-
Colao A, Ferone D, Marzullo P, Lombardi G 2004 Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152 (Pubitemid 38269977)
-
(2004)
Endocrine Reviews
, vol.25
, Issue.1
, pp. 102-152
-
-
Colao, A.1
Ferone, D.2
Marzullo, P.3
Lombardi, G.4
-
22
-
-
12144287620
-
Diagnosis and treatment of acromegaly complications
-
Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA, Gaillard R, Ho K, Jaquet P, Kleinberg DL, Lamberts SW, Lombardi G, Sheppard M, Strasburger CJ, Vance ML, Wass JA, Melmed S 2003 Diagnosis and treatment of acromegaly complications. J Endocrinol Invest 26:1242-1247 (Pubitemid 38324744)
-
(2003)
Journal of Endocrinological Investigation
, vol.26
, Issue.12
, pp. 1242-1247
-
-
Giustina, A.1
Casanueva, F.F.2
Cavagnini, F.3
Chanson, P.4
Clemmons, D.5
Frohman, L.A.6
Gaillard, R.7
Ho, K.8
Jaquet, P.9
Kleinberg, D.L.10
Lamberts, S.W.J.11
Lombardi, G.12
Sheppard, M.13
Strasburger, C.J.14
Vance, M.L.15
Wass, J.A.H.16
Melmed, S.17
-
23
-
-
0035123881
-
Relationship between blood pressure and glucose tolerance in acromegaly
-
DOI 10.1046/j.1365-2265.2001.01206.x
-
Jaffrain-Rea ML, Moroni C, Baldelli R, Battista C, Maffei P, Terzolo M, Correra M, Ghiggi MR, Ferretti E, Angeli A, Sicolo N, Trischitta V, Liuzzi A, Cassone R, Tamburrano G 2001 Relationship between blood pressure and glucose tolerance in acromegaly. Clin Endocrinol (Oxf) 54:189-195 (Pubitemid 32193520)
-
(2001)
Clinical Endocrinology
, vol.54
, Issue.2
, pp. 189-195
-
-
Jaffrain-Rea, M.-L.1
Moroni, C.2
Baldelli, R.3
Battista, C.4
Maffei, P.5
Terzolo, M.6
Correra, M.7
Ghiggi, M.R.8
Ferretti, E.9
Angeli, A.10
Sicolo, N.11
Trischitta, V.12
Liuzzi, A.13
Cassone, R.14
Tamburrano, G.15
-
24
-
-
0023005812
-
Glucose tolerance during long term treatment with a somatostatin analogue
-
Verschoor L, Lamberts SW, Uitterlinden P, Del Pozo E 1986 Glucose tolerance during long term treatment with a somatostatin analogue. Br Med J 293:1327-1328 (Pubitemid 17181792)
-
(1986)
British Medical Journal
, vol.293
, Issue.6558
, pp. 1327-1328
-
-
Verschoor, L.1
Lamberts, S.W.J.2
Uitterlinden, P.3
Del Pozo, E.4
-
25
-
-
0023110899
-
Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995)
-
Sandler LM, Burrin JM, Williams G, Joplin GF, Carr DH, Bloom SR 1987 Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995). Clin Endocrinol (Oxf) 26:85-95 (Pubitemid 17015969)
-
(1987)
Clinical Endocrinology
, vol.26
, Issue.1
, pp. 85-95
-
-
Sandler, L.M.1
Burrin, J.M.2
Williams, G.3
-
26
-
-
0023637579
-
Long term treatment of acromegaly with sandostatin (SMS201-995)
-
Pieters GFFM, van Liessum PA, Smalls AGH, van Gennep JA, Benraad THJ, Kloppenborg PWC 1987 Long term treatment of acromegaly with sandostatin (SMS201-995). Acta Endocrinol 286s:9-18
-
(1987)
Acta Endocrinol
, vol.286 S
, pp. 9-18
-
-
Pieters, G.F.F.M.1
Van Liessum, P.A.2
Smalls, A.G.H.3
Van Gennep, J.A.4
Benraad, T.H.J.5
Kloppenborg, P.W.C.6
-
27
-
-
0025164701
-
Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group
-
Sassolas G, Harris AG, James-Deidier A 1990 Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group. J Clin Endocrinol Metab 71:391-397
-
(1990)
J Clin Endocrinol Metab
, vol.71
, pp. 391-397
-
-
Sassolas, G.1
Harris, A.G.2
James-Deidier, A.3
-
28
-
-
0025319336
-
A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: Clinical and biochemical effects
-
Halse J, Harris AG, Kvistborg A, Kjartansson O, Hanssen E, Smiseth O, Djøsland O, Hass G, Jervell J 1990 A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects. J Clin Endocrinol Metab 70:1254-1261 (Pubitemid 20159056)
-
(1990)
Journal of Clinical Endocrinology and Metabolism
, vol.70
, Issue.5
, pp. 1254-1261
-
-
Halse, J.1
Harris, A.G.2
Kvistborg, A.3
Kjartansson, O.4
Hanssen, E.5
Smiseth, O.6
Djosland, O.7
Hass, G.8
Jervell, J.9
-
29
-
-
0025166386
-
Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide
-
Page MD, Millward ME, Taylor A, Preece M, Hourihan M, Hall R, Scanlon MF 1990 Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide. Q J Med 74:189-201 (Pubitemid 20059790)
-
(1990)
Quarterly Journal of Medicine
, vol.74
, Issue.274
, pp. 189-201
-
-
Page, M.D.1
Millward, M.E.2
Taylor, A.3
Preece, M.4
Hourihan, M.5
Hall, R.6
Scanlon, M.F.7
-
30
-
-
0025190143
-
Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety
-
Ho KY, Weissberger AJ, Marbach P, Lazarus L 1990 Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. Ann Intern Med 112:173-181
-
(1990)
Ann Intern Med
, vol.112
, pp. 173-181
-
-
Ho, K.Y.1
Weissberger, A.J.2
Marbach, P.3
Lazarus, L.4
-
31
-
-
0025895476
-
Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide
-
James RA, Møller N, Chatterjee S, White M, Kendall-Taylor P 1991 Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide. Diabet Med 8:517-523
-
(1991)
Diabet Med
, vol.8
, pp. 517-523
-
-
James, R.A.1
Møller, N.2
Chatterjee, S.3
White, M.4
Kendall-Taylor, P.5
-
32
-
-
0025783499
-
Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group
-
Vance ML, Harris AG 1991 Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group. Arch Intern Med 151:1573-1578
-
(1991)
Arch Intern Med
, vol.151
, pp. 1573-1578
-
-
Vance, M.L.1
Harris, A.G.2
-
33
-
-
0026560276
-
Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly
-
(Oxf)
-
Ho KK, Jenkins AB, Furler SM, Borkman M, Chisholm DJ 1992 Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clin Endocrinol (Oxf) 36:271-279
-
(1992)
Clin Endocrinol
, vol.36
, pp. 271-279
-
-
Ho, K.K.1
Jenkins, A.B.2
Furler, S.M.3
Borkman, M.4
Chisholm, D.J.5
-
34
-
-
0026787125
-
Octreotide treatment of acromegaly. A randomized, multicenter study
-
Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L, Cook DM, Malarkey WB, Jackson I, Vance ML, Thorner MO, Barkan A, Frohman LA, Melmed S 1992 Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 117:711-718
-
(1992)
Ann Intern Med
, vol.117
, pp. 711-718
-
-
Ezzat, S.1
Snyder, P.J.2
Young, W.F.3
Boyajy, L.D.4
Newman, C.5
Klibanski, A.6
Molitch, M.E.7
Boyd, A.E.8
Sheeler, L.9
Cook, D.M.10
Malarkey, W.B.11
Jackson, I.12
Vance, M.L.13
Thorner, M.O.14
Barkan, A.15
Frohman, L.A.16
Melmed, S.17
-
35
-
-
0027741436
-
Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly
-
Lam KS, Pang RW, Janus ED, Kung AW, Wang CC 1993 Serum apolipoprotein (a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis 104:183-188 (Pubitemid 24035646)
-
(1993)
Atherosclerosis
, vol.104
, Issue.1-2
, pp. 183-188
-
-
Lam, K.S.L.1
Pang, R.W.C.2
Janus, E.D.3
Kung, A.W.C.4
Wang, C.C.L.5
-
36
-
-
0027168793
-
Octreotide long term treatment of acromegaly: Effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values
-
DOI 10.1210/jc.77.1.157
-
Plöckinger U, Liehr RM, Quabbe HJ 1993 Octreotide long term treatment of acromegaly: effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values. J Clin Endocrinol Metab 77:157-162 (Pubitemid 23206795)
-
(1993)
Journal of Clinical Endocrinology and Metabolism
, vol.77
, Issue.1
, pp. 157-162
-
-
Plockinger, U.1
Liehr, R.-M.2
Quabbe, H.-J.3
-
37
-
-
0028222326
-
Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide
-
DOI 10.1210/jc.79.1.145
-
Morange I, De Boisvilliers F, Chanson P, Lucas B, DeWailly D, Catus F, Thomas F, Jaquet P 1994 Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide. J Clin Endocrinol Metab 79:145-151 (Pubitemid 24221174)
-
(1994)
Journal of Clinical Endocrinology and Metabolism
, vol.79
, Issue.1
, pp. 145-151
-
-
Morange, I.1
De Boisvilliers, F.2
Chanson, P.3
Lucas, B.4
Dewailly, D.5
Catus, F.6
Thomas, F.7
Jaquet, P.8
-
38
-
-
0028286788
-
Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide
-
Marek J, Hána V, Krsek M, Justová V, Catus F, Thomas F 1994 Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide. Eur J Endocrinol 131:20-26 (Pubitemid 24230548)
-
(1994)
European Journal of Endocrinology
, vol.131
, Issue.1
, pp. 20-26
-
-
Marek, J.1
Hana, V.2
Krsek, M.3
Justova, V.4
Catus, F.5
Thomas, F.6
-
41
-
-
0029038128
-
Long-term effect of octreotide in acromegaly on insulin resistance
-
Breidert M, Pinzer T, Wildbrett J, Bornstein SR, Hanefeld M 1995 Long-term effect of octreotide in acromegaly on insulin resistance. Horm Metab Res 27:226-230
-
(1995)
Horm Metab Res
, vol.27
, pp. 226-230
-
-
Breidert, M.1
Pinzer, T.2
Wildbrett, J.3
Bornstein, S.R.4
Hanefeld, M.5
-
42
-
-
0028822452
-
Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase
-
Simsolo RB, Ezzat S, Ong JM, Saghizadeh M, Kern PA 1995 Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase. J Clin Endocrinol Metab 80:3233-3238
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 3233-3238
-
-
Simsolo, R.B.1
Ezzat, S.2
Ong, J.M.3
Saghizadeh, M.4
Kern, P.A.5
-
43
-
-
0029586762
-
Short-term effects of octreotide on glucose tolerance in patients with acromegaly
-
Sato K, Takamatsu K, Hashimoto K 1995 Short-term effects of octreotide on glucose tolerance in patients with acromegaly. Endocr J 42:739-745 (Pubitemid 26038687)
-
(1995)
Endocrine Journal
, vol.42
, Issue.6
, pp. 739-745
-
-
Sato, K.1
Takamatsu, K.2
Hashimoto, K.3
-
44
-
-
0028882919
-
Effects of treatment with octreotide in acromegalic patients-a multicenter Italian study
-
Italian Multicenter Octreotide Study Group.
-
Arosio M, Macchelli S, Rossi CM, Casati G, Biella O, Faglia G 1995 Effects of treatment with octreotide in acromegalic patients-a multicenter Italian study. Italian Multicenter Octreotide Study Group. Eur J Endocrinol 133:430-439
-
(1995)
Eur J Endocrinol
, vol.133
, pp. 430-439
-
-
Arosio, M.1
Macchelli, S.2
Rossi, C.M.3
Casati, G.4
Biella, O.5
Faglia, G.6
-
45
-
-
0029804842
-
The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly
-
al-Maskari M, Gebbie J, Kendall-Taylor P 1996 The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly. Clin Endocrinol 45:415-421
-
(1996)
Clin Endocrinol
, vol.45
, pp. 415-421
-
-
Al-Maskari, M.1
Gebbie, J.2
Kendall-Taylor, P.3
-
47
-
-
0030891582
-
Clinical results of long-term slow-release lanreotide treatment of acromegaly
-
Giusti M, Ciccarelli E, Dallabonzana D, Delitala G, Faglia G, Liuzzi A, Gussoni G, Giordano G 1997 Clinical results of long-term slow-release lanreotide treatment of acromegaly. Eur J Clin Invest 27:277-284 (Pubitemid 27163251)
-
(1997)
European Journal of Clinical Investigation
, vol.27
, Issue.4
, pp. 277-284
-
-
Giusti, M.1
Ciccarelli, E.2
Dallabonzana, D.3
Delitala, G.4
Faglia, G.5
Liuzzi, A.6
Gussoni, G.7
Giordano Disem, G.8
-
48
-
-
0031930952
-
Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly
-
DOI 10.1046/j.1365-2265.1998.00389.x
-
Davies PH, Stewart SE, Lancranjan L, Sheppard MC, Stewart PM 1998 Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly. Clin Endocrinol 48:311-316 (Pubitemid 28137643)
-
(1998)
Clinical Endocrinology
, vol.48
, Issue.3
, pp. 311-316
-
-
Davies, P.H.1
Stewart, S.E.2
Lancranjan, I.3
Sheppard, M.C.4
Stewart, P.M.5
-
49
-
-
0033291744
-
Results of a European multicentre study with Sandostatin LAR in acromegalic patients
-
Sandostatin LAR Group
-
Lancranjan I, Atkinson AB 1999 Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group. Pituitary 1:105-114
-
(1999)
Pituitary
, vol.1
, pp. 105-114
-
-
Lancranjan, I.1
Atkinson, A.B.2
-
50
-
-
0032828008
-
A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly
-
DOI 10.1530/eje.0.1410267
-
Cozzi R, Dallabonzana D, Attanasio R, Barausse M, Oppizzi G 1999 A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly. Eur J Endocrinol 141:267-271 (Pubitemid 29465932)
-
(1999)
European Journal of Endocrinology
, vol.141
, Issue.3
, pp. 267-271
-
-
Cozzi, R.1
Dallabonzana, D.2
Attanasio, R.3
Barausse, M.4
Oppizzi, G.5
-
51
-
-
0032839205
-
Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide
-
Suliman M, Jenkins R, Ross R, Powell T, Battersby R, Cullen DR 1999 Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide. J Endocrinol Invest 22:409-418 (Pubitemid 29355556)
-
(1999)
Journal of Endocrinological Investigation
, vol.22
, Issue.6
, pp. 409-418
-
-
Suliman, M.1
Jenkins, R.2
Ross, R.3
Powell, T.4
Battersby, R.5
Cullen, D.R.6
-
52
-
-
0034433176
-
Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegaly
-
Kendall-Taylor P, Miller M, Gebbie J, Turner S, al-Maskari M 2000 Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegaly. Pituitary 3:61-65
-
(2000)
Pituitary
, vol.3
, pp. 61-65
-
-
Kendall-Taylor, P.1
Miller, M.2
Gebbie, J.3
Turner, S.4
Al-Maskari, M.5
-
53
-
-
0035000997
-
Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide
-
Díez JJ, Iglesias P, Gó mez-Pan A 2001 Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide. J Endocrinol Invest 24:303-309
-
(2001)
J Endocrinol Invest
, vol.24
, pp. 303-309
-
-
Díez, J.J.1
Iglesias, P.2
Gómez-Pan, A.3
-
54
-
-
0034974291
-
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly
-
DOI 10.1210/jc.86.6.2779
-
Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G 2001 Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779-2786 (Pubitemid 32545739)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.6
, pp. 2779-2786
-
-
Colao, A.1
Ferone, D.2
Marzullo, P.3
Cappabianca, P.4
Cirillo, S.5
Boerlin, V.6
Lancranjan, I.7
Lombardi, G.8
-
55
-
-
0036123501
-
Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly
-
Ambrosio MR, Franceschetti P, Bondanelli M, Doga M, Maffei P, Baldelli R, Tamburrano G, Sicolo N, Giustina A, degli Uberti EC 2002 Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly. Metabolism 51:387-393
-
(2002)
Metabolism
, vol.51
, pp. 387-393
-
-
Ambrosio, M.R.1
Franceschetti, P.2
Bondanelli, M.3
Doga, M.4
Maffei, P.5
Baldelli, R.6
Tamburrano, G.7
Sicolo, N.8
Giustina, A.9
Degli Uberti, E.C.10
-
56
-
-
0036738337
-
Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly
-
Ayuk J, Stewart SE, Stewart PM, Sheppard MC 2002 Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly. J Clin Endocrinol Metab 87:4142-4146
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4142-4146
-
-
Ayuk, J.1
Stewart, S.E.2
Stewart, P.M.3
Sheppard, M.C.4
-
57
-
-
0036205121
-
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly
-
Colao A, Marzullo P, Lombardi G 2002 Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly. Eur J Endocrinol 146:303-309 (Pubitemid 34257639)
-
(2002)
European Journal of Endocrinology
, vol.146
, Issue.3
, pp. 303-309
-
-
Colao, A.1
Marzullo, P.2
Lombardi, G.3
Cozzi, R.4
Barausse, M.5
Faglia, G.6
Arosio, M.7
Giordano, G.8
Giusti, M.9
Ghiggi, M.R.10
Battista, C.11
Mantero, F.12
Arnaldi, G.13
Martino, E.14
Gasperi, M.15
Sicolo, N.16
Martini, C.17
Valcavi, R.18
Zini, M.19
Arcispedale, S.20
more..
-
58
-
-
0036318922
-
Cardiovascular consequences of earlyonset growth hormone excess
-
Colao A, Spinelli L, Cuocolo A, Spiezia S, Pivonello R, di Somma C, Bonaduce D, Salvatore M, Lombardi G 2002 Cardiovascular consequences of earlyonset growth hormone excess. J Clin Endocrinol Metab 87:3097-3104
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3097-3104
-
-
Colao, A.1
Spinelli, L.2
Cuocolo, A.3
Spiezia, S.4
Pivonello, R.5
Di Somma, C.6
Bonaduce, D.7
Salvatore, M.8
Lombardi, G.9
-
59
-
-
0035987927
-
Effects of two different somatostatin analogs on glucose tolerance in acromegaly
-
Ronchi C, Epaminonda P, Cappiello V, Beck-Peccoz P, Arosio M 2002 Effects of two different somatostatin analogs on glucose tolerance in acromegaly. J Endocrinol Invest 25:502-507 (Pubitemid 34661837)
-
(2002)
Journal of Endocrinological Investigation
, vol.25
, Issue.6
, pp. 502-507
-
-
Ronchi, C.1
Epaminonda, P.2
Cappiello, V.3
Beck-Peccoz, P.4
Arosio, M.5
-
60
-
-
0038644714
-
The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly
-
Smith JC, Lane H, Davies N, Evans LM, Cockcroft J, Scanlon MF, Davies JS 2003 The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly. J Clin Endocrinol Metab 88:2556-2561 (Pubitemid 36724423)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.6
, pp. 2556-2561
-
-
Smith, J.C.1
Lane, H.2
Davies, N.3
Evans, L.M.4
Cockcroft, J.5
Scanlon, M.F.6
Davies, J.S.7
-
61
-
-
10744220389
-
Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly
-
DOI 10.1210/jc.2003-030266
-
Attanasio R, Baldelli R, Pivonello R, Grottoli S, Bocca L, Gasco V, Giusti M, Tamburrano G, Colao A, Cozzi R 2003 Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly. J Clin Endocrinol Metab 88:5258-5265 (Pubitemid 37452725)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.11
, pp. 5258-5265
-
-
Attanasio, R.1
Baldelli, R.2
Pivonello, R.3
Grottoli, S.4
Bocca, L.5
Gasco, V.6
Giusti, M.7
Tamburrano, G.8
Colao, A.9
Cozzi, R.10
-
62
-
-
0037693074
-
Serum ghrelin levels in acromegaly: Effects of surgical and long-acting octreotide therapy
-
DOI 10.1210/jc.2002-021683
-
Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw SL 2003 Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J Clin Endocrinol Metab 88:2037-2044 (Pubitemid 36549874)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.5
, pp. 2037-2044
-
-
Freda, P.U.1
Reyes, C.M.2
Conwell, I.M.3
Sundeen, R.E.4
Wardlaw, S.L.5
-
63
-
-
0042525843
-
Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues
-
Ronchi CL, Orsi E, Giavoli C, Cappiello V, Epaminonda P, Beck-Peccoz P, Beck-Peccoz P, Arosio M 2003 Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues. J Endocrinol Invest 26:533-538 (Pubitemid 36998702)
-
(2003)
Journal of Endocrinological Investigation
, vol.26
, Issue.6
, pp. 533-538
-
-
Ronchi, C.L.1
Orsi, E.2
Giavoli, C.3
Cappiello, V.4
Epaminonda, P.5
Beck-Peccoz, P.6
Arosio, M.7
-
64
-
-
10744228519
-
Glucose homeostasis in acromegaly: Effects of long-acting somatostatin analogues treatment
-
DOI 10.1046/j.1365-2265.2003.01876.x
-
Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D'Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V, Tamburrano G 2003 Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment. Clin Endocrinol (Oxf) 59:492-499 (Pubitemid 37188181)
-
(2003)
Clinical Endocrinology
, vol.59
, Issue.4
, pp. 492-499
-
-
Baldelli, R.1
Battista, C.2
Leonetti, F.3
Ghiggi, M.-R.4
Ribaudo, M.-C.5
Paoloni, A.6
D'Amico, E.7
Ferretti, E.8
Baratta, R.9
Liuzzi, A.10
Trischitta, V.11
Tamburrano, G.12
-
65
-
-
1542316208
-
Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy
-
Baldelli R, Durante C, D'Amico E, Diacono F, Tamburrano G, Casanueva FF 2003 Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy. J Endocrinol Invest 26:1219-1224 (Pubitemid 38324741)
-
(2003)
Journal of Endocrinological Investigation
, vol.26
, Issue.12
, pp. 1219-1224
-
-
Baldelli, R.1
Durante, C.2
D'Amico, E.3
Diacono, F.4
Tamburrano, G.5
Casanueva, F.F.6
-
66
-
-
17144431786
-
Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel)
-
DOI 10.1055/s-2005-837520
-
Gutt B, Bidlingmaier M, Kretschmar K, Dieterle C, Steffin B, Schopohl J 2005 Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel). Exp Clin Endocrinol Diabetes 113:139-144 (Pubitemid 40516354)
-
(2005)
Experimental and Clinical Endocrinology and Diabetes
, vol.113
, Issue.3
, pp. 139-144
-
-
Gutt, B.1
Bidlingmaier, M.2
Kretschmar, K.3
Dieterle, C.4
Steffin, B.5
Schopohl, J.6
-
67
-
-
26244434860
-
Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist
-
Jørgensen JO, Feldt-Rasmussen U, Frystyk J, Chen JW, Kristensen LØ, Hagen C, Ørskov H 2005 Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist. J Clin Endocrinol Metab 90:5627-5631
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 5627-5631
-
-
Jørgensen, J.O.1
Feldt-Rasmussen, U.2
Frystyk, J.3
Chen, J.W.4
Kristensen, L.Ø.5
Hagen, C.6
Orskov, H.7
-
68
-
-
23244442834
-
Treatment of acromegaly with octreotide-LAR: Extensive experience in a Brazilian institution
-
DOI 10.1111/j.1365-2265.2005.02317.x
-
Jallad RS, Musolino NR, Salgado LR, Bronstein MD 2005 Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Clin Endocrinol (Oxf) 63:168-175 (Pubitemid 41097985)
-
(2005)
Clinical Endocrinology
, vol.63
, Issue.2
, pp. 168-175
-
-
Jallad, R.S.1
Musolino, N.R.C.2
Salgado, L.R.3
Bronstein, M.D.4
-
69
-
-
33645025605
-
Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly
-
(Oxf)
-
Caron P, Cogne M, Raingeard I, Bex-Bachellerie V, Kuhn JM 2006 Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly. Clin Endocrinol (Oxf) 64:209-214
-
(2006)
Clin Endocrinol
, vol.64
, pp. 209-214
-
-
Caron, P.1
Cogne, M.2
Raingeard, I.3
Bex-Bachellerie, V.4
Kuhn, J.M.5
-
70
-
-
30344460510
-
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: Effects on cardiovascular risk factors
-
DOI 10.1210/jc.2005-1704
-
Ronchi CL, Varca V, Beck-Peccoz P, Orsi E, Donadio F, Baccarelli A, Giavoli C, Ferrante E, Lania A, Spada A, Arosio M 2006 Comparison between sixyear therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J Clin Endocrinol Metab 91:121-128 (Pubitemid 43069127)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.1
, pp. 121-128
-
-
Ronchi, C.L.1
Varca, V.2
Beck-Peccoz, P.3
Orsi, E.4
Donadio, F.5
Baccarelli, A.6
Giavoli, C.7
Ferrante, E.8
Lania, A.9
Spada, A.10
Arosio, M.11
-
71
-
-
35848967790
-
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA
-
DOI 10.1007/s11102-007-0037-7
-
De Marinis L, Bianchi A, Fusco A, Cimino V, Mormando M, Tilaro L, Mazziotti G, Pontecorvi A, Giustina A 2007 Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. Pituitary 10:227-232 (Pubitemid 350055033)
-
(2007)
Pituitary
, vol.10
, Issue.3
, pp. 227-232
-
-
De Marinis, L.1
Bianchi, A.2
Fusco, A.3
Cimino, V.4
Mormando, M.5
Tilaro, L.6
Mazziotti, G.7
Pontecorvi, A.8
Giustina, A.9
-
72
-
-
34447513998
-
Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa
-
DOI 10.1111/j.1365-2265.2007.02878.x
-
Maiza JC, Vezzosi D, Matta M, Donadille F, Loubes-Lacroix F, Cournot M, Bennet A, Caron P 2007 Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa. Clin Endocrinol (Oxf) 67:282-289 (Pubitemid 47076308)
-
(2007)
Clinical Endocrinology
, vol.67
, Issue.2
, pp. 282-289
-
-
Maiza, J.C.1
Vezzosi, D.2
Matta, M.3
Donadille, F.4
Loubes-Lacroix, F.5
Cournot, M.6
Bennet, A.7
Caron, P.8
-
74
-
-
0003505146
-
-
New York: John Wiley, Sons Inc.
-
Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F 2000 Methods for meta-analysis in medical research: Wiley series in probability and statistics. New York: John Wiley, Sons Inc.
-
(2000)
Methods for Meta-analysis in Medical Research: Wiley Series in Probability and Statistics
-
-
Sutton, A.J.1
Abrams, K.R.2
Jones, D.R.3
Sheldon, T.A.4
Song, F.5
-
75
-
-
84948773232
-
Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis
-
Egger M, Smith GD, Altman DG, eds. London: BMJ Publishing Group
-
Deeks JJ, Altman DG, Bradburn MJ 2001 Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in healthcare: metaanalysis in context. 2nd ed. London: BMJ Publishing Group; 285-312
-
(2001)
Systematic Reviews in Healthcare: Metaanalysis in Context. 2nd Ed.
, pp. 285-312
-
-
Deeks, J.J.1
Altman, D.G.2
Bradburn, M.J.3
-
76
-
-
0037098199
-
Quantifying heterogeneity in a meta-analysis
-
DOI 10.1002/sim.1186
-
Higgins JP, Thompson SG 2002 Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558 (Pubitemid 34746062)
-
(2002)
Statistics in Medicine
, vol.21
, Issue.11
, pp. 1539-1558
-
-
Higgins, J.P.T.1
Thompson, S.G.2
-
77
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
Higgins JP, Thompson SG, Deeks JJ, Altman DG 2003 Measuring inconsistency in meta-analyses. BMJ 327:557-560 (Pubitemid 37088507)
-
(2003)
British Medical Journal
, vol.327
, Issue.7414
, pp. 557-560
-
-
Higgins, J.P.T.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
78
-
-
0025700486
-
Medical progress: Acromegaly
-
Melmed S 2006 Medical progress: acromegaly. N Engl J Med 355:2558-2573 (Pubitemid 20146631)
-
(1990)
New England Journal of Medicine
, vol.322
, Issue.14
, pp. 966-977
-
-
Melmed, S.1
-
79
-
-
40849102466
-
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor
-
Baldelli R, De Marinis L, Bianchi A, Pivonello R, Gasco V, Auriemma R, Pasimeni G, Cimino V, Appetecchia M, Maccario M, Lombardi G, Pontecorvi A, Colao A, Grottoli S 2008 Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab 93:710-714
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 710-714
-
-
Baldelli, R.1
De Marinis, L.2
Bianchi, A.3
Pivonello, R.4
Gasco, V.5
Auriemma, R.6
Pasimeni, G.7
Cimino, V.8
Appetecchia, M.9
Maccario, M.10
Lombardi, G.11
Pontecorvi, A.12
Colao, A.13
Grottoli, S.14
-
80
-
-
0032239547
-
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
-
Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797 (Pubitemid 128506521)
-
(1998)
Endocrine Reviews
, vol.19
, Issue.6
, pp. 717-797
-
-
Giustina, A.1
Veldhuis, J.D.2
-
81
-
-
0038813735
-
Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly
-
DOI 10.1023/A:1023321421760
-
Clemmons DR 2002 Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5:181-183 (Pubitemid 36656431)
-
(2002)
Pituitary
, vol.5
, Issue.3
, pp. 181-183
-
-
Clemmons, D.R.1
-
82
-
-
48349128492
-
Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery
-
Höybye C, Chandramouli V, Efendic S, Hulting AL, Landau BR, Schumann WC, Wajngot A 2008 Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery. Horm Metab Res 40:498-501
-
(2008)
Horm Metab Res
, vol.40
, pp. 498-501
-
-
Höybye, C.1
Chandramouli, V.2
Efendic, S.3
Hulting, A.L.4
Landau, B.R.5
Schumann, W.C.6
Wajngot, A.7
-
83
-
-
18544363593
-
Acromegaly Treatment Consensus Workshop Participants. Guidelines for acromegaly management
-
Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, Werder KV, Wass J, Giustina A 2002 Acromegaly Treatment Consensus Workshop Participants. Guidelines for acromegaly management. J Clin Endocrinol Metab 87:4054-4058
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4054-4058
-
-
Melmed, S.1
Casanueva, F.F.2
Cavagnini, F.3
Chanson, P.4
Frohman, L.5
Grossman, A.6
Ho, K.7
Kleinberg, D.8
Lamberts, S.9
Laws, E.10
Lombardi, G.11
Vance, M.L.12
Werder, K.V.13
Wass, J.14
Giustina, A.15
-
84
-
-
25444517599
-
Increased prevalence of radiological spinal deformities in active acromegaly: A cross-sectional study in postmenopausal women
-
Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A 2005 Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J Bone Miner Res 20:1837-1844
-
(2005)
J Bone Miner Res
, vol.20
, pp. 1837-1844
-
-
Bonadonna, S.1
Mazziotti, G.2
Nuzzo, M.3
Bianchi, A.4
Fusco, A.5
De Marinis, L.6
Giustina, A.7
-
85
-
-
34249845852
-
Impact of somatostatin analogs on the heart in acromegaly: A metaanalysis
-
DOI 10.1210/jc.2006-2547
-
Maison P, Tropeano AI, Macquin-Mavier I, Giustina A, Chanson P 2007 Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. J Clin Endocrinol Metab 92:1743-1747 (Pubitemid 46997181)
-
(2007)
Journal of Clinical Endocrinology and Metabolism
, vol.92
, Issue.5
, pp. 1743-1747
-
-
Maison, P.1
Tropeano, A.-I.2
Macquin-Mavier, I.3
Giustina, A.4
Chanson, P.5
-
86
-
-
49549111375
-
Growth hormone, insulin-like growth factors, and the skeleton
-
Giustina A, Mazziotti G, Canalis E 2008 Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535-559
-
(2008)
Endocr Rev
, vol.29
, pp. 535-559
-
-
Giustina, A.1
Mazziotti, G.2
Canalis, E.3
-
87
-
-
0034465470
-
Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: An in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice
-
Strowski MZ, Parmar RM, Blake AD, Schaeffer JM 2000 Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 141:111-117
-
(2000)
Endocrinology
, vol.141
, pp. 111-117
-
-
Strowski, M.Z.1
Parmar, R.M.2
Blake, A.D.3
Schaeffer, J.M.4
-
88
-
-
33746273283
-
Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly
-
DOI 10.1530/eje.1.02185
-
Steffin B, Gutt B, Bidlingmaier M, Dieterle C, Oltmann F, Schopohl J 2006 Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly. Eur J Endocrinol 155:73-78 (Pubitemid 44103377)
-
(2006)
European Journal of Endocrinology
, vol.155
, Issue.1
, pp. 73-78
-
-
Steffin, B.1
Gutt, B.2
Bidlingmaier, M.3
Dieterle, C.4
Oltmann, F.5
Schopohl, J.6
-
89
-
-
0034690311
-
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
-
DOI 10.1056/NEJM200004203421604
-
Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ 2000 Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171-1177 (Pubitemid 30211048)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.16
, pp. 1171-1177
-
-
Trainer, P.J.1
Drake, W.M.2
Katznelson, L.3
Freda, P.U.4
Herman-Bonert, V.5
Van Der Lely, A.J.6
Dimaraki, E.V.7
Stewart, P.M.8
Friend, K.E.9
Vance, M.L.10
Besser, G.M.11
Scarlett, J.A.12
-
90
-
-
0036800303
-
Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly
-
DOI 10.1210/er.2001-0022
-
Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ 2002 Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 23:623-646 (Pubitemid 35191626)
-
(2002)
Endocrine Reviews
, vol.23
, Issue.5
, pp. 623-646
-
-
Kopchick, J.J.1
Parkinson, C.2
Stevens, E.C.3
Trainer, P.J.4
-
91
-
-
0035944825
-
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
-
DOI 10.1016/S0140-6736(01)06844-1
-
van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO 2001 Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 24:1754-1759 (Pubitemid 33152999)
-
(2001)
Lancet
, vol.358
, Issue.9295
, pp. 1754-1759
-
-
Van Der Lely, A.J.1
Hutson, R.K.2
Trainer, P.J.3
Besser, G.M.4
Barkan, A.L.5
Katznelson, L.6
Klibanski, A.7
Herman-Bonert, V.8
Melmed, S.9
Vance, M.L.10
Freda, P.U.11
Stewart, P.M.12
Friend, K.E.13
Clemmons, D.R.14
Johannsson, G.15
Stavrou, S.16
Cook, D.M.17
Phillips, L.S.18
Strasburger, C.J.19
Hacker, S.20
Zib, K.A.21
Davis, R.J.22
Scarlett, J.A.23
Thorner, M.O.24
more..
-
92
-
-
0034037529
-
Impaired β-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
-
DOI 10.1046/j.1365-2265.2000.00986.x
-
Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, Koga M, Saitoh Y, Ohnishi T, Arita N 2000 Impaired β-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf) 52:549-555 (Pubitemid 30337079)
-
(2000)
Clinical Endocrinology
, vol.52
, Issue.5
, pp. 549-555
-
-
Kasayama, S.1
Otsuki, M.2
Takagi, M.3
Saito, H.4
Sumitani, S.5
Kouhara, H.6
Koga, M.7
Saitoh, Y.8
Ohnishi, T.9
Arita, N.10
-
93
-
-
0021906772
-
Production of insulin resistance by hyperinsulinaemia in man
-
Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE 1985 Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28:70-75 (Pubitemid 15128811)
-
(1985)
Diabetologia
, vol.28
, Issue.2
, pp. 70-75
-
-
Rizza, R.A.1
Mandarino, L.J.2
Genest, J.3
-
94
-
-
33846943674
-
Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: An in vitro study on isolated human pancreatic islets
-
Singh V, Brendel MD, Zacharias S, Mergler S, Jahr H, Wiedenmann B, Bretzel RG, Plöckinger U, Strowski MZ 2007 Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. J Clin Endocrinol Metab 92:673-680
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 673-680
-
-
Singh, V.1
Brendel, M.D.2
Zacharias, S.3
Mergler, S.4
Jahr, H.5
Wiedenmann, B.6
Bretzel, R.G.7
Plöckinger, U.8
Strowski, M.Z.9
-
95
-
-
0022354853
-
Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995
-
Lamberts SW, Uitterlinden P, Verschoor L, van Dongen KJ, del Pozo E 1985 Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med 313:1576-1580 (Pubitemid 16177397)
-
(1985)
New England Journal of Medicine
, vol.313
, Issue.25
, pp. 1576-1580
-
-
Lamberts, S.W.J.1
Uitterlinden, P.2
Verschoor, L.3
-
96
-
-
17744371632
-
Criteria for cure of acromegaly: A consensus statement
-
DOI 10.1210/jc.85.2.526
-
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529 (Pubitemid 32273628)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.2
, pp. 526-529
-
-
Giustina, A.1
Barkan, A.2
Casanueva, F.F.3
Cavagnini, F.4
Frohman, L.5
Ho, K.6
Veldhuis, J.7
Wass, J.8
Von Werder, K.9
Melmed, S.10
-
97
-
-
29644441517
-
Consensus statement: Medical management of acromegaly
-
DOI 10.1530/eje.1.02036
-
Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R, Ghigo E, Ho K, Jaquet P, Kleinberg D, Lamberts S, Laws E, Lombardi G, Sheppard MC, Thorner M, Vance ML, Wass JA, Giustina A 2005 Consensus statement: medical management of acromegaly. Eur J Endocrinol 153:737-740 (Pubitemid 43020222)
-
(2005)
European Journal of Endocrinology
, vol.153
, Issue.6
, pp. 737-740
-
-
Melmed, S.1
Casanueva, F.2
Cavagnini, F.3
Chanson, P.4
Frohman, L.A.5
Gaillard, R.6
Ghigo, E.7
Ho, K.8
Jaquet, P.9
Kleinberg, D.10
Lamberts, S.11
Laws, E.12
Lombardi, G.13
Sheppard, M.C.14
Thorner, M.15
Vance, M.L.16
Wass, J.A.H.17
Giustina, A.18
-
98
-
-
18444366740
-
Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant
-
DOI 10.1210/jc.87.4.1692
-
Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, Dimaraki E, Stavrou S, Vance ML, Hayden D, Klibanski A 2002 Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab 87:1692-1699 (Pubitemid 34615258)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.4
, pp. 1692-1699
-
-
Sesmilo, G.1
Fairfield, W.P.2
Katznelson, L.3
Pulaski, K.4
Freda, P.U.5
Bonert, V.6
Dimaraki, E.7
Stavrou, S.8
Vance, M.L.9
Hayden, D.10
Klibanski, A.11
-
99
-
-
0346728594
-
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant
-
DOI 10.1530/eje.0.1490521
-
Drake WM, Rowles SV, Roberts ME, Fode FK, Besser GM, Monson JP, Trainer PJ 2003 Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant. Eur J Endocrinol 149:521-527 (Pubitemid 38054695)
-
(2003)
European Journal of Endocrinology
, vol.149
, Issue.6
, pp. 521-527
-
-
Drake, W.M.1
Rowles, S.V.2
Roberts, M.E.3
Fode, F.K.4
Besser, G.M.5
Monson, J.P.6
Trainer, P.J.7
-
100
-
-
26244464853
-
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant
-
DOI 10.1210/jc.2005-0331
-
Barkan AL, Burman P, Clemmons DR, Drake WM, Gagel RF, Harris PE, Trainer PJ, van der Lely AJ, Vance ML 2005 Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant. J Clin Endocrinol Metab 90:5684-5691 (Pubitemid 41415476)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.10
, pp. 5684-5691
-
-
Barkan, A.L.1
Burman, P.2
Clemmons, D.R.3
Drake, W.M.4
Gagel, R.F.5
Harris, P.E.6
Trainer, P.J.7
Van Der Lely, A.J.8
Vance, M.L.9
-
101
-
-
33645221483
-
Efficacy of 12-month treatment with theGHreceptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: Effect on IGF-I levels, tumor mass, hypertension and glucose tolerance
-
Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G 2006 Efficacy of 12-month treatment with theGHreceptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol 154:467-477
-
(2006)
Eur J Endocrinol
, vol.154
, pp. 467-477
-
-
Colao, A.1
Pivonello, R.2
Auriemma, R.S.3
De Martino, M.C.4
Bidlingmaier, M.5
Briganti, F.6
Tortora, F.7
Burman, P.8
Kourides, I.A.9
Strasburger, C.J.10
Lombardi, G.11
|